Genetic mutations affecting JAK3 expression or function result in autosomal
recessive SCID. Children affected with JAK3-deficient SCID present with vi
rtual absence of T lymphocytes and NK cells, whereas B lymphocytes usually
are normal or elevated in number but functionally defective. Because of the
profound impairment of cellular and humoral immunity, patients with JAK3 d
eficiency are exposed to recurrent and life-threatening infections unless i
mmune reconstitution is achieved by allogeneic bone marrow transplantation.
The identification of JAK3 as a key player in the development of the immun
e system in humans has stimulated many studies detailing the biologic chara
cteristics of this important molecule, and has opened the way to possible g
enetic intervention.